Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

Presentation TCT 2014

A Novel Multi Lumen Compliant Balloon Catheter (ND® Infusion Catheter) Preserves Stem Cell Viability and Improves Dispersion When Compared to a Standard Single Lumen Balloon___

Presenter: Nabil Dib

September 16, 2014

News Conference News TCT 2014

Experts Disagree Over Endovascular Therapy for Acute Stroke

September 15, 2014

Presentation TCT 2014

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Maurice E. Sarano

September 13, 2014

Presentation TCT 2013

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Presenter: Robert Bonow

October 29, 2013

Presentation TCT 2013

Stem Cell Viability Significantly Reduced After Passing Through a Standard Single Lumen Over-the-Wire 0.014' Balloon Angioplasty Catheter

Presenter: Nabil Dib

October 29, 2013

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making

Presenter: Marcelo Di Carli

October 23, 2012

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

Advertisement

Companies With Innovative Technologies Compete in TCT Shark Tank

A Novel Multi Lumen Compliant Balloon Catheter (ND® Infusion Catheter) Preserves Stem Cell Viability and Improves Dispersion When Compared to a Standard Single Lumen Balloon___

Experts Disagree Over Endovascular Therapy for Acute Stroke

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Stem Cell Viability Significantly Reduced After Passing Through a Standard Single Lumen Over-the-Wire 0.014' Balloon Angioplasty Catheter

Future Looks Bright for Stem Cell-Based Myocardial Therapy

Viability Testing, Clinical Decision Making(2)

Viability Testing, Clinical Decision Making

TAVR Bioprosthesis Safe, Effective at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content